Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,651 | -6,464 | -4,056 | -1,663 | -8,357 |
| Depreciation Amortization | 2 | 2 | 1 | 1 | 16 |
| Accounts payable and accrued liabilities | 1,335 | 330 | 592 | 233 | -238 |
| Other Working Capital | 1,873 | 240 | 334 | -336 | 144 |
| Other Operating Activity | 84 | 326 | -237 | -71 | 4,905 |
| Operating Cash Flow | $-7,358 | $-5,567 | $-3,366 | $-1,836 | $-3,530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | N/A | N/A | N/A | -3 |
| Investing Cash Flow | $-7 | $N/A | $N/A | $N/A | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,806 | 1,528 | 0 | 0 | 12,154 |
| Other Financing Activity | 4,173 | 0 | 0 | 0 | -250 |
| Financing Cash Flow | $8,980 | $1,528 | $0 | $0 | $11,904 |
| Beginning Cash Position | 8,403 | 8,403 | 8,403 | 8,403 | 33 |
| End Cash Position | 10,018 | 4,364 | 5,037 | 6,566 | 8,403 |
| Net Cash Flow | $1,615 | $-4,039 | $-3,365 | $-1,836 | $8,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,358 | -5,567 | -3,366 | -1,836 | -3,530 |
| Capital Expenditure | -7 | N/A | N/A | N/A | -3 |
| Free Cash Flow | -7,364 | -5,567 | -3,366 | -1,836 | -3,534 |